User menu

Cytogenetic remissions in high-risk myelodysplastic syndrome: Results in 124 patients treated with low-dose 5-aza-2 '-deoxycytidine (Decitabine), a DNA methylation inhibitor.

Bibliographic reference Lubbert, M ; Ferrant, Augustin ; Wijermans, P ; Kunzmann, R ; Verhoef, G. ; et. al. Cytogenetic remissions in high-risk myelodysplastic syndrome: Results in 124 patients treated with low-dose 5-aza-2 '-deoxycytidine (Decitabine), a DNA methylation inhibitor..In: Blood, Vol. 96, no. 11, p. 546A-+ (2000)
Permanent URL http://hdl.handle.net/2078.1/62021